Literature DB >> 19394599

A novel single-cell DNA fingerprinting method successfully distinguishes sibling human embryos.

Nathan R Treff1, Jing Su, Xin Tao, Kathleen A Miller, Brynn Levy, Richard T Scott.   

Abstract

OBJECTIVE: To validate a novel system for embryonic DNA fingerprinting which can reliably distinguish sibling embryos from each other.
DESIGN: Prospective, randomized, and blinded study.
SETTING: Academic center for reproductive medicine. PATIENT(S): Blastomeres were obtained from discarded and transferred embryos from six patients undergoing IVF treatment. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Single lymphocytes from sibling cell lines and blastomeres from sibling day 3 human embryos were evaluated for accurate assignment of relationship using whole genome amplification and single-nucleotide polymorphism microarrays. RESULT(S): Assignment of single-cell relationships was accomplished with 100% accuracy. We also observed complete agreement between the molecular karyotype and DNA fingerprint-based identification of embryos implanted in three clinical IVF cases after multiple embryo transfer. CONCLUSION(S): These data demonstrate the first single-blastomere DNA fingerprinting technology capable of unequivocal discrimination of sibling human embryos. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19394599     DOI: 10.1016/j.fertnstert.2009.03.067

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  Singling out genetic disorders and disease.

Authors:  Martine De Rycke
Journal:  Genome Med       Date:  2010-10-06       Impact factor: 11.117

2.  Trophectoderm DNA fingerprinting by quantitative real-time PCR successfully distinguishes sibling human embryos.

Authors:  Richard T Scott; Jing Su; Xin Tao; Eric J Forman; Kathleen H Hong; Deanne Taylor; Nathan R Treff
Journal:  J Assist Reprod Genet       Date:  2014-08-17       Impact factor: 3.412

Review 3.  Chromosomal disorders and male infertility.

Authors:  Gary L Harton; Helen G Tempest
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

4.  SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts.

Authors:  L E Northrop; N R Treff; B Levy; R T Scott
Journal:  Mol Hum Reprod       Date:  2010-05-17       Impact factor: 4.025

Review 5.  Benefits and limitations of genome-wide association studies.

Authors:  Vivian Tam; Nikunj Patel; Michelle Turcotte; Yohan Bossé; Guillaume Paré; David Meyre
Journal:  Nat Rev Genet       Date:  2019-08       Impact factor: 53.242

6.  Telomere DNA deficiency is associated with development of human embryonic aneuploidy.

Authors:  Nathan R Treff; Jing Su; Deanne Taylor; Richard T Scott
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

Review 7.  Methods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validity.

Authors:  Nathan R Treff; Richard T Scott
Journal:  J Assist Reprod Genet       Date:  2012-03-14       Impact factor: 3.412

8.  Delivery of a chromosomally normal child from an oocyte with reciprocal aneuploid polar bodies.

Authors:  Richard T Scott; Nathan R Treff; John Stevens; Eric J Forman; Kathleen H Hong; Mandy G Katz-Jaffe; William B Schoolcraft
Journal:  J Assist Reprod Genet       Date:  2012-03-30       Impact factor: 3.412

9.  Preimplantation genetic diagnosis for aneuploidy and translocations using array comparative genomic hybridization.

Authors:  Santiago Munné
Journal:  Curr Genomics       Date:  2012-09       Impact factor: 2.236

10.  Comprehensive chromosome analysis of blastocysts before implantation using array CGH.

Authors:  Mi Kyung Chung; Sang-Jin Park; Hyeon Jeong Jeong; Jung Hyun Lee; Hee-Doo Chung; Ho-Young Kang
Journal:  Mol Cytogenet       Date:  2013-06-03       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.